Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)

NCT00056823 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-Related Maculopathy

Interventions

DRUG: rhuFab V2 (ranibizumab)

Sponsor

Genentech, Inc.